NCT04245436View on ClinicalTrials.gov

Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

July 31, 2025

Study Completion Date

August 31, 2025

Conditions
AnxietyDepressive Symptoms
Interventions
DRUG

Duloxetine

Encapsulated duloxetine 30 mg, 60 mg; once-daily

DRUG

Escitalopram

Encapsulated escitalopram 5 mg, 10 mg, 15 mg, 20 mg; once-daily

Trial Locations (1)

45219

RECRUITING

University of Cincinnati, Cincinnati

All Listed Sponsors
lead

University of Cincinnati

OTHER